Colorectal Cancer Screening - JE Part B
Colorectal Cancer Screening
Medicare covers several colorectal cancer screening services, including stool-based tests, screening colonoscopy, flexible sigmoidoscopy, and computed tomography (CT) colonography. Before submitting a claim, verify the beneficiary's age, risk status, screening history, and frequency eligibility to ensure Medicare coverage requirements are met.
Use the information below to identify covered screening options, determine applicable frequency limitations, report the appropriate HCPCS or CPT code, and apply modifiers when required. Reviewing eligibility and billing requirements before claim submission can help reduce denials and support accurate claim processing.
On this page:
- High Risk Conditions
- Blood-based Biomarker Test
- Fecal Occult Blood Test
- Stool DNA Testing
- Complete Colorectal Cancer Screening
- Flexible Sigmoidoscopy
- Screening Colonoscopy
- Surveillance Colonoscopy
- Barium Enema Screening
- Computed Tomography (CT) Colonography
- Screening Becomes Diagnostic
- Anesthesia and Colonoscopy
- Incomplete/Discontinued Procedure
- Evaluation and Management (E/M) Services
- Noridian Medicare Portal
- Resources
High Risk Conditions
Determine whether the beneficiary meets Medicare's high-risk criteria before billing a high-risk colorectal cancer screening service. Risk status affects both coverage and screening frequency limitations.
High Risk Conditions include:
- Close relative (sibling, parent, or child) who has had colorectal cancer or
anadenomatous polyp - Family history of familial adenomatous polyposis
- Family history of hereditary nonpolyposis colorectal cancer
- Personal history of adenomatous polyps
- Personal history of colorectal cancer
- Personal history of inflammatory bowel disease, including Crohn's Disease and ulcerative colitis
Accurately identifying high-risk beneficiaries helps ensure the correct screening code, coverage criteria, and frequency limitations are applied.
Blood-based Biomarker Test
Bill HCPCS code G0327 when performing a colorectal cancer screening using a blood-based biomarker test. Before submitting a claim, verify that the beneficiary is 45 through 85 years of age, asymptomatic, and at average risk for colorectal cancer.
Medicare covers this screening test once every three years for beneficiaries who meet the coverage requirements. Confirming eligibility and frequency limitations before billing helps ensure accurate claim processing and reduces the risk of denials.
When coverage criteria are met, Medicare waives both the deductible and coinsurance, resulting in no beneficiary cost-sharing for this preventive screening service.
Fecal Occult Blood Test
Bill CPT code 82270 or HCPCS code G0328 when performing a covered fecal occult blood test for colorectal cancer screening. Before submitting a claim, verify that the beneficiary is 45 years of age or older and at average risk for colorectal cancer, or meets Medicare's high-risk criteria.
Medicare covers one FOBT screening once every 12 months. Providers may bill 82270 in place of G0328; however, both services are not covered during the same 12-month period. Verifying frequency requirements before billing helps prevent denials and ensures accurate claim processing.
When coverage requirements are met, Medicare waives both the deductible and coinsurance, resulting in no beneficiary cost-sharing for this preventive screening service.
Stool DNA Testing
Bill CPT code 81528 for Cologuard or PLA code 0464U for Cologuard Plus when performing a covered stool DNA colorectal cancer screening test. Before submitting a claim, verify that the beneficiary is 45 through 85 years of age, asymptomatic, and at average risk for colorectal cancer.
Medicare covers stool DNA testing once every three years for beneficiaries who meet the coverage requirements. Report the appropriate screening diagnosis code(s), including:
- Z12.11 - Encounter for screening for malignant neoplasm of colon
- Z12.12 - Encounter for screening for malignant neoplasm of rectum
Using the appropriate diagnosis code helps support medical necessity and promotes accurate claim processing.
For Part A claims, report revenue code 030X on TOBs 13X, 14X (non-patient laboratory specimens only), and 85X, as applicable.
When coverage requirements are met, Medicare waives both the deductible and coinsurance, resulting in no beneficiary cost-sharing for this preventive screening service.
Complete Colorectal Cancer Screening
When a beneficiary receives a screening colonoscopy following a positive result from a non-invasive stool-based colorectal cancer screening test, bill the colonoscopy as a complete colorectal cancer screening rather than a diagnostic procedure. Before submitting the claim, verify that the colonoscopy was performed as follow-up to a covered non-invasive stool-based screening test.
Append modifier KX to the screening colonoscopy claim to identify that the service was performed as part of a complete colorectal cancer screening. Reporting modifier KX allows Medicare to recognize the colonoscopy as a continuation of the screening process and apply the appropriate preventive screening benefits.
Using the correct modifier helps ensure accurate claim processing and reduces the risk of billing errors or unnecessary claim denials.
Flexible Sigmoidoscopy
Bill HCPCS code G0104 when performing a covered screening flexible sigmoidoscopy. Before submitting a claim, verify that the beneficiary is 45 years of age or older and determine whether the beneficiary meets Medicare's high-risk criteria for colorectal cancer, as frequency limitations vary based on risk status and prior screening history.
For beneficiaries at high risk, Medicare covers a screening flexible sigmoidoscopy once every 48 months. For beneficiaries who are not at high risk, Medicare also covers the service once every 48 months. However, if the beneficiary has received a screening colonoscopy (G0121) within the previous 10 years, coverage for a screening flexible sigmoidoscopy is generally available only after at least 119 months have passed since the month the colonoscopy was performed.
Verifying eligibility and frequency limitations before billing helps ensure accurate claim processing and reduces the risk of claim denials. When Medicare coverage requirements are met, both the deductible and coinsurance are waived.
If a screening flexible sigmoidoscopy becomes diagnostic during the procedure, report the appropriate diagnostic code and append modifier PT to indicate the service began as a screening procedure. Medicare applies a phased reduction in beneficiary coinsurance for these services:
- Calendar Years 2023-2026: 15% coinsurance
- Calendar Years 2027-2029: 10% coinsurance
- Calendar Year 2030 and beyond: No coinsurance
Using modifier PT correctly helps Medicare apply the appropriate cost-sharing and process the claim accurately.
Screening Colonoscopy
Bill the screening colonoscopy code that matches the beneficiary's colorectal cancer risk status. Report HCPCS code G0105 for beneficiaries who meet Medicare's high-risk criteria and HCPCS code G0121 for beneficiaries who are not considered high risk.
Before submitting a claim, verify that the beneficiary meets the applicable frequency requirements. For beneficiaries at high risk, Medicare covers a screening colonoscopy once every 24 months. However, if a screening flexible sigmoidoscopy was previously performed, coverage is available only after at least 47 months have passed. For beneficiaries who are not at high risk, Medicare covers a screening colonoscopy once every 10 years, or 48 months after a previous screening flexible sigmoidoscopy.
Confirming eligibility and frequency limitations before billing helps ensure accurate claim processing and reduces the risk of claim denials. When Medicare coverage requirements are met, both the deductible and coinsurance are waived.
If a screening colonoscopy becomes diagnostic during the procedure, report the appropriate diagnostic colonoscopy code and append modifier PT to indicate the service began as a screening procedure. Medicare applies a phased reduction in beneficiary coinsurance for these services:
- Calendar Years 2023-2026: 15% coinsurance
- Calendar Years 2027-2029: 10% coinsurance
- Calendar Year 2030 and beyond: No coinsurance
Using modifier PT correctly helps Medicare apply the appropriate preventive service cost-sharing and process the claim accurately.
Surveillance Colonoscopy
Do not determine whether a colonoscopy is screening or diagnostic based solely on the term "surveillance." Instead, review the beneficiary's medical history, risk factors, and reason for the procedure before selecting the appropriate code.
If the beneficiary has a personal history of adenomatous polyps or another condition that meets Medicare's high-risk criteria, and the procedure is being performed as a preventive screening service, report HCPCS code G0105 when all coverage requirements are met. Correctly identifying high-risk beneficiaries helps ensure the appropriate screening benefits and frequency limitations are applied.
If the colonoscopy is performed to evaluate signs, symptoms, abnormal findings, or another diagnostic indication, report the appropriate diagnostic colonoscopy code rather than a screening code.
When a screening colonoscopy becomes therapeutic or requires additional intervention during the procedure, report the appropriate diagnostic colonoscopy code and append modifier PT to indicate the service began as a screening colonoscopy. Using modifier PT helps Medicare apply the appropriate cost-sharing requirements and process the claim accurately.
Example: A beneficiary with a personal history of adenomatous polyps who meets Medicare's high-risk criteria may qualify for a high-risk screening colonoscopy when the procedure is performed for preventive screening purposes and all coverage requirements are met. In this situation, report HCPCS code G0105.
Barium Enema Screening
Do not bill HCPCS codes G0106 or G0120 for colorectal cancer screening services provided on or after January 1, 2025. Medicare no longer recognizes screening barium enema as a covered colorectal cancer screening method.
Before submitting a claim for colorectal cancer screening, verify that the service is a currently covered screening option and report the appropriate screening code. Using an active Medicare-covered screening service helps ensure accurate claim processing and reduces the risk of claim denials.
For additional information about this coverage change and other colorectal cancer screening updates, refer to CMS Medicare Learning Network (MLN) Matters (MM) 14031.
Computed Tomography (CT) Colonography
Bill CPT code 74263 when performing a covered screening CT colonography. Before submitting a claim, verify that the beneficiary is 45 years of age or older, asymptomatic, and eligible based on Medicare's colorectal cancer screening coverage requirements.
Medicare covers screening CT colonography at different intervals depending on the beneficiary's risk status and prior screening history:
- Average risk: Once every 5 years, provided at least 59 months have passed since the month of the last screening CT colonography.
- Average risk with a prior screening colonoscopy or flexible sigmoidoscopy: Once every 4 years, provided at least 47 months have passed since the month of the last screening colonoscopy or flexible sigmoidoscopy.
- High risk: Once every 2 years, provided at least 23 months have passed since the month of the last screening CT colonography or screening colonoscopy.
Before billing, confirm that the beneficiary meets the applicable frequency limitation and risk criteria. Verifying eligibility helps ensure accurate claim processing and reduces the risk of claim denials.
A beneficiary may qualify for coverage if they are at average risk for colorectal cancer or meet Medicare's high-risk criteria when reported with an appropriate high-risk diagnosis code.
When coverage requirements are met, Medicare waives both the deductible and coinsurance, resulting in no beneficiary cost-sharing for this preventive screening service.
Screening Becomes Diagnostic
When a screening colonoscopy or flexible sigmoidoscopy becomes diagnostic during the procedure, report the appropriate diagnostic CPT or HCPCS code and append modifier PT. Report the screening diagnosis as the primary diagnosis and the abnormal finding as a secondary diagnosis. When applicable, link the abnormal finding diagnosis to the diagnostic procedure code.
Using modifier PT identifies that the service began as a screening procedure and allows Medicare to apply the appropriate cost-sharing requirements.
If laboratory or pathology services are associated with a diagnostic colonoscopy, report a diagnosis that reflects the diagnostic indication rather than a screening diagnosis. Do not append modifiers PT or 33 to laboratory or pathology services.
When modifier PT is reported, beneficiary coinsurance is reduced according to the following schedule:
- Calendar Years 2023-2026: 15% coinsurance
- Calendar Years 2027-2029: 10% coinsurance
- Calendar Year 2030 and beyond: No coinsurance
Anesthesia and Colonoscopy
Report CPT code 00812 when anesthesia is furnished for a screening colonoscopy. When billed appropriately as a preventive service, Medicare waives both the deductible and coinsurance.
If a screening colonoscopy becomes diagnostic during the procedure, report CPT code 00811 with modifier PT and bill the appropriate diagnostic colonoscopy code. In these situations, the deductible remains waived and Medicare applies the applicable beneficiary coinsurance amount.
Do not append modifier PT to anesthesia codes 00730, 00740, or 00813. Medicare does not recognize modifier 33 for colonoscopy anesthesia services.
Using the correct anesthesia code and modifier helps ensure accurate claim processing and proper application of beneficiary cost-sharing.
Incomplete/Discontinued Procedure
When a colonoscopy cannot be completed due to unforeseen circumstances, append modifier 53 and reduce the billed amount before submitting the claim. Medicare generally allows payment at one-half of the value of the billed procedure when modifier 53 is reported appropriately.
Do not bill for procedures that are cancelled before any preparation or services are performed.
For services performed in an Ambulatory Surgical Center (ASC), append:
- Modifier 73 when the procedure is discontinued before anesthesia administration
- Modifier 74 when the procedure is discontinued after anesthesia administration
Using the appropriate modifier helps Medicare process the claim correctly and reduces the likelihood of payment delays or denials.
Evaluation and Management (E/M) Services
Do not bill a separate E/M service on the same day as a screening colonoscopy when the beneficiary was referred solely for the procedure and no significant, separately identifiable evaluation was performed. In these situations, the E/M service is generally considered part of the colonoscopy and is not separately payable.
A separate E/M service may be appropriate when the beneficiary presents with symptoms or concerns that require additional evaluation beyond the screening procedure. For example, if the beneficiary reports abdominal pain, bleeding, or other symptoms that require a medically necessary examination and clinical decision-making, a separate E/M service may be billed when supported by the medical record.
Appropriate documentation should clearly demonstrate that the evaluation was distinct from the screening colonoscopy and medically necessary for the beneficiary's condition.
Noridian Medicare Portal
Use the Noridian Medicare Portal to verify eligibility, review claim status, and access information for covered colorectal cancer screening services. Checking eligibility and screening history before submitting a claim can help identify frequency limitations and reduce billing errors.
The following colorectal cancer screening services are available in the Noridian Medicare Portal:
- 81528
- 82270
- 0464U
- G0104
- G0105
- G0121
- G0327
- G0328
- 74263
This information can help providers verify preventive screening services and support accurate claim submission.
Resources
- CMS Internet Only Manual (IOM), Publication 100-02, Medicare Benefit Policy Manual, Chapter 15, Section 280.2
- CMS IOM, Publication 100-04, Medicare Claims Processing Manual, Chapter 18, Section 60
- CMS Medicare Learning Network (MLN) Matters (MM) 12656 - Changes to Beneficiary Coinsurance for Additional Procedures Furnished During the Same Clinical Encounter As Certain Colorectal Cancer Screening Tests
- CMS MM 13017 - Removal of a National Coverage Determination & Expansion of Coverage of Colorectal Cancer Screening
- CMS Medicare Preventive Services
- CMS National Coverage Determination (NCD) 210.3